NID1 and hepatocellular carcinoma: Importantly, the perturbation of the lung endothelial wall by tumor-EVs was also demonstrated in a model of hepatocellular carcinoma (HCC), where tumor-EVs carrying Nidogen 1 (NID1) enhanced angiogenesis and pulmonary endothelial permeability (65).